Entreprise quantique

Menten AI

Generative AI platform combining physics-based models and quantum simulations to design peptide macrocycle drugs.

San Francisco, United States Quantum Computing SW
Visiter le site Soumettre une info sur cette entreprise

Technologie

Menten AI develops MAUD 1.0, a platform that designs peptide macrocycles for difficult drug targets by combining generative AI with physics-based models and quantum simulations. The company went through Y Combinator (Winter 2020) and raised a $4 million seed round in June 2020.

Financée par 1 investisseur

Liens externes

Visiter le site Soumettre une info sur cette entreprise